Uwe brings more than 16 years in the life sciences BD&L environment and 13 years as a practicing physician (board qualified pediatrician, Germany) and scientist to consulting projects. He specializes in assisting life science companies and academic institutions in the US, Europe and Asia in their licensing, financing and M&A activities. Prior to co-founding ActeaVentures in 2014 Uwe has run PharmaSearchEval LLC (later: Peukert-Advisors, Inc.) - a US-based boutique business development consulting firm - since 2011. In August 2011, Uwe has joined the management team of Torrey Pines Investment, Inc. (San Diego, USA) as “SVP Strategic Investment Initiatives”. Prior to his work as independent consultant Uwe held several key roles in BD&L in big pharma (Roche and Eli Lilly), big biotech (Onyx Pharmaceuticals) and small biotech (NewVac LLC) as well as in Venture Capital (Torreypines Investment). During his tenure at Onyx Pharmaceuticals Uwe initiated and lead the technical evaluation/DD resulting in the acquisition of Proteolix Inc (2009, South San Francisco) and the out-licensing of Japanese rights to Carfilzomib to Ono Pharmaceuticals (2010, Osaka/Japan). In his time at Eli Lilly & Co Uwe triggered and completed the technical and business evaluation leading to the acquisition of Imclone ($6.3 billion deal value, 2008). At Roche, Uwe was fully accountable for the opt-in business case supporting the decision to license Avastin from Genentech to Roche in 2003. Uwe holds an MD degree (1987), and a PhD (Dr.med.) in toxicology (1990) from Medizinische Hochschule Hannover, Germany. He received an MBA degree from Manchester Business School, UK (2001). Uwe served his pediatric residency in the University Hospitals of Bonn and Lübeck, Germany, and received his board qualification for pediatrics in 1996. SPECIALTIES: BD&L, Licensing, M&A, financing, product strategy, pipeline optimization, portfolio planning, Oncology, Specialty & Primary Care, medical devices, diagnostics.
Since March 2014
ActeaVentures is a global advisory firm offering comprehensive BD&L services to the Life Sciences industry, i.e. Pharma – Biotech – Diagnostics – MedTech - RegenMed. It has its roots in three independent Business Development consultancies: JP.BioConsulting (Germany), Actea Partnering (Spain) and PharmaSearchEval (USA)/Peukert-Advisors, Inc. (USA). Going forward, ActeaVentures provides the experience, the combined partnering networks and the track records of its predecessors which is complemented by the skills, professional networks and knowledge of a global team of Senior Consultants. Together we make sure that our clients successfully execute licensing agreements, development and commercialization partnerships, acquisitions and divestments. Our team of Senior BD&L professionals will be using its extensive network of personal contacts in the Life Sciences industry in order to match your project with the right partner. Our experience from many executed licensing agreements and transactions allows us to help you in signing the right partnering deal at the right terms. We will also help you to present your programs or your company with fully optimized documents and presentations that will significantly improve the probability of finding the best partner and achieving favorable deal terms.
President & CEO
Since December 2013
Providing advice to multinational pharmaceutical companies, small startups, biotechs and Venture and Investment Bank investors in the life sciences industry. Based on 16 years as a practicing physician, truly global international experience, business development positions in two major pharmaceutical companies (Roche, Lilly) and one mid cap pharmaceutical company (Onyx) over the past 11 years. Expertise in program evaluation, scouting, business forcasting - finding the next important pharmaceutical blockbuster or niche-buster drug. Driven by unmet medical need, knowing the patient and scientific rigor and integrity. Getting the right deal(s) done.
Chief Medical Adviser (Acting CMO)
October 2011 --- July 2014
Acting Chief Medical Officer. Conceptualizing, planning, executing clinical studies in the field of cancer immunotherpies and combination therapies.
Senior Vice President
June 2011 --- July 2014
President and CEO
April 2011 --- July 2014
Boutique specialty consultancy for the life sciences industry. Succeeded by Peukert-Advisors Inc.
Head of Scouting and Evaluation Corporate Development
January 2009 --- March 2011
Identification and evaluation of business development partnering opportunities to complement pipeline and creation and implementation of a partnering strategy to build a product pipeline in execution of on an active growth strategy.
Director of External Research & Development (Oncology)
October 2004 --- January 2009
Partnering (licensing, acquisition, collaboration) of external innovation in the field of oncology into LLY. Deals: Kyowa Hakko (Eg5 inhibitor), Deciphera discovery collaboration, SGX acquisition, Imclone acquisition.
Business Development Mgr/Dir (Procurist)
April 2001 --- October 2004
* Global function across Basel, Switzerland and Nutley, USA. * Licensing product deals (in-licensing, out-licensing, co-promotion. * Broad alliances, mergers, acquisitions within the Pharmaceutical and Biotechnolog industries. * Disease Areas: Primary Care (Metabolism, Cardiovascular, Lipids) and Oncology, Supportive Care (Anemia, Pain, etc). * Job requires work in matrix teams along the business development process, from strategic and portfolio planning, to prospecting, initiating, business evaluation, Due Diligence, Negotiations and Alliance Management. * Full responsibility Business Case (forecast and P&L based on science, target product profile and market and cost analysis) and presentation to Senior Management, CEO (High visibility) * Lots of travelling required. * 18 months long-term assignment in Nutley, NJ, USA.
Full time MBA
October 1999 --- March 2001
* 18 months full-time MBA Programme * Summer Internship with Janssen Pharmaceutica/Belgium (a J&J company) in the gastrointestinal franchise (analogue analysis on genericization issues) * Exchange term in Handelshochschule Leipzig (HHL), Leipzig Business School * Project: Business Plan for a startup CRO in Germany (Zentrum fuer Therapiestudien, Innomed Leipzig GmbH)
Self employed pediatrician (own practice/office)
October 1996 --- September 1999
Growing pediatric practice in Northern Germany, rural setting, 5 staff, authorization to conduct color-doppler echocardiography examinations
Senior Registrar in NICU, Med. Univ. Luebeck
February 1994 --- September 1996
Scientific assistant, senior registrar, specialization in neonatology, intensive care, pediatric cardiology (echocardiography), responsible for hospital communication system, controlling and mentoring,
SHO and registrar in Pediatrics
October 1989 --- January 1994
Scientific assistant, SHO and registrar, general pediatric, pediatric oncology, outpatient clinics metabolic disorders, cardiology, echocardiography, pediatric intensive care, neonatology, pediatric A&E, responsible for toxicology information centre and IT-solutions
Surgeon-major/captain airforce (compulsory service)
July 1988 --- September 1989
leading military base health care unit. Responsible for 20 ambulance soldiers. A&E, propedeutics, family care medicine.
PhD Research Fellow
June 1987 --- June 1988
Research fellow, conducting major research work, lecturing for students in toxicology and pharmacology, PhD Toxicology (1990, Hannover, Germany)
Analytical thinkingAdaptabilityAuthenticityCollaborationCompetitivenessCreative thinkingDependabilityDiligenceInnovative thinkingInterest in knowledgeProactivityProblem solvingResiliencyStrategic thinkingSelf-disciplineResponsibility
Skills and Expertise
business developmentclinical developmentProvide medical content for clinical development plannon-clinical developmentDevelop clinical strategyDevelop regulatory strategyAdvise on strategyCorporate DevelopmentCancerPediatricsCritical CareInfectionMetabolismCardio-vascularNeonatologypharmacology
MBA in full time MBA, general from Alliance Manchester Business School in 2001
Board Certified Pediatrician (Germany, license current) in Pediatric Medicine from Universities of Bonn & Luebeck (Germany) in 1996
PhD in Toxicology-Medicine from Medizinische Hochschule Hannover in 1990
MD in Human Medicine from Medizinische Hochschule Hannover in 1987
Training and Certification
Board Certified Pediatrician (Germany, current license) in 1996 Certification
Expert has 4 publications (Will be avalible with full profile)